These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 9163739)
1. Reassembly and reconstitution of separate alpha and beta chains of human leukocyte antigen DR4 molecule isolated from Escherichia coli. Kang JH; Maeng CY; Park JH; Hahm KS; Han BD; Kim KL Mol Cells; 1997 Apr; 7(2):237-43. PubMed ID: 9163739 [TBL] [Abstract][Full Text] [Related]
2. Refolding and reconstitution of functionally active complexes of human leukocyte antigen DR2 and myelin basic protein peptide from recombinant alpha and beta polypeptide chains. Arimilli S; Cardoso C; Mukku P; Baichwal V; Nag B J Biol Chem; 1995 Jan; 270(2):971-7. PubMed ID: 7529765 [TBL] [Abstract][Full Text] [Related]
3. Refolding of human class II major histocompatibility complex molecules isolated from Escherichia coli. Assembly of peptide-free heterodimers and increased refolding-yield in the presence of antigenic peptide. Stöckel J; Meinl E; Hahnel C; Malotka J; Seitz R; Drexler K; Wekerle H; Dornmair K J Biol Chem; 1994 Nov; 269(47):29571-8. PubMed ID: 7961943 [TBL] [Abstract][Full Text] [Related]
4. Intramolecular charge heterogeneity in purified major histocompatibility class II alpha and beta polypeptide chains. Nag B; Arimilli S; Koukis B; Rhodes E; Baichwal V; Sharma SD J Biol Chem; 1994 Apr; 269(13):10061-70. PubMed ID: 8144505 [TBL] [Abstract][Full Text] [Related]
5. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens. Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029 [TBL] [Abstract][Full Text] [Related]
6. Structure of a complex of the human alpha/beta T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): insight into TCR cross-restriction and alloreactivity. Hennecke J; Wiley DC J Exp Med; 2002 Mar; 195(5):571-81. PubMed ID: 11877480 [TBL] [Abstract][Full Text] [Related]
7. Refolding and reassembly of separate alpha and beta chains of class II molecules of the major histocompatibility complex leads to increased peptide-binding capacity. Dornmair K; McConnell HM Proc Natl Acad Sci U S A; 1990 Jun; 87(11):4134-8. PubMed ID: 2349223 [TBL] [Abstract][Full Text] [Related]
8. [Cloning of human beta-microglobulin gene and its high expression in Escherichia coli]. He XH; Xu LH; Liu Y; Zeng YY Sheng Wu Gong Cheng Xue Bao; 2004 Jan; 20(1):99-103. PubMed ID: 16108498 [TBL] [Abstract][Full Text] [Related]
9. Formation of functional peptide complexes of class II major histocompatibility complex proteins from subunits produced in Escherichia coli. Altman JD; Reay PA; Davis MM Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10330-4. PubMed ID: 8234294 [TBL] [Abstract][Full Text] [Related]
10. Pathway of detergent-mediated and peptide ligand-mediated refolding of heterodimeric class II major histocompatibility complex (MHC) molecules. Stöckel J; Döring K; Malotka J; Jähnig F; Dornmair K Eur J Biochem; 1997 Sep; 248(3):684-91. PubMed ID: 9342218 [TBL] [Abstract][Full Text] [Related]
11. Functionally active recombinant alpha and beta chain-peptide complexes of human major histocompatibility class II molecules. Nag B; Arimilli S; Mukku PV; Astafieva I J Biol Chem; 1996 Apr; 271(17):10413-8. PubMed ID: 8626615 [TBL] [Abstract][Full Text] [Related]
12. Peptide binding to soluble HLA-DR4 molecules produced by insect cells. Scheirle A; Takacs B; Kremer L; Marin F; Sinigaglia F J Immunol; 1992 Sep; 149(6):1994-9. PubMed ID: 1387668 [TBL] [Abstract][Full Text] [Related]
13. [Construction and characterization of soluble HLA-A*0201-PR1 complex]. Sun WJ; Xu DG; Hu HL; Zou MJ; DU JF; Wang JF; Cai X; Wang JX; Ai HS Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):352-6. PubMed ID: 17493346 [TBL] [Abstract][Full Text] [Related]
14. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis. Ito K; Bian HJ; Molina M; Han J; Magram J; Saar E; Belunis C; Bolin DR; Arceo R; Campbell R; Falcioni F; Vidović D; Hammer J; Nagy ZA J Exp Med; 1996 Jun; 183(6):2635-44. PubMed ID: 8676084 [TBL] [Abstract][Full Text] [Related]
15. Baculoviral expressed HLA class I heavy chains used to screen a synthetic peptide library for allele-specific peptide binding motifs. Smith MH; Nuara AA; Egen JG; Sirjani DB; Lam KS; Grimes WJ Mol Immunol; 1998 Nov; 35(16):1033-43. PubMed ID: 10068038 [TBL] [Abstract][Full Text] [Related]
16. Identification of a CD4 binding site on the beta 2 domain of HLA-DR molecules. Cammarota G; Scheirle A; Takacs B; Doran DM; Knorr R; Bannwarth W; Guardiola J; Sinigaglia F Nature; 1992 Apr; 356(6372):799-801. PubMed ID: 1574119 [TBL] [Abstract][Full Text] [Related]
17. Preparation of the extracellular domain of the rabbit prolactin receptor expressed in Escherichia coli and its interaction with lactogenic hormones. Bignon C; Sakal E; Belair L; Chapnik-Cohen N; Djiane J; Gertler A J Biol Chem; 1994 Feb; 269(5):3318-24. PubMed ID: 8106371 [TBL] [Abstract][Full Text] [Related]
18. Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region beta-chain T-cell repertoire and mediates an HLA-DR-restricted immune response. Fugger L; Michie SA; Rulifson I; Lock CB; McDevitt GS Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6151-5. PubMed ID: 8016129 [TBL] [Abstract][Full Text] [Related]
19. Canine thyrotropin beta-subunit gene: cloning and expression in Escherichia coli, generation of monoclonal antibodies, and transient expression in the Chinese hamster ovary cells. Yanga X; McGraw RA; Su X; Katakam P; Grosse WM; Li OW; Ferguson DC Domest Anim Endocrinol; 2000 May; 18(4):363-78. PubMed ID: 10869856 [TBL] [Abstract][Full Text] [Related]
20. HLA-DR4 (DRB1*0401) transgenic mice expressing an altered CD4-binding site: specificity and magnitude of DR4-restricted T cell response. Pan S; Trejo T; Hansen J; Smart M; David CS J Immunol; 1998 Sep; 161(6):2925-9. PubMed ID: 9743354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]